https://clinicaltrials.gov/ct2/show/NCT01058343?type=Intr&cond=Lupus&phase=012345&lupd_s=03%2F07%2F2019&lupd_d=14
Condition : Systemic Lupus Erythematosus
Intervention : Biological: IFN-K
Sponsor : Neovacs
Completed
Safety of IFNa Kinoid in Systemic Lupus Erythematosus
NCT01058343
Thu, 28 Jan 2010 12:00:00 EST
